Progression-free survival - PDFSEARCH.IO - Document Search Engine

Progression-free survival
Results: 42

#	Item
1	UNIVERSITÄTSKLINIKUM Schleswig-Holstein Immuntherapie des Glioblastoms Sampson et al. - Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Add to Reading List Source URL: www.neuro.uni-luebeck.de Language: German - Date: 2014-03-27 09:47:19
2	Guideline on CT in Small Populations - Adopted Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 04:57:34 Medical research Clinical research Research Health Clinical trials Medical statistics Design of experiments Epidemiology Surrogate endpoint Analysis of clinical trials Clinical endpoint Progression-free survival
3	MayImproving Trial Success by Improving Tumor Assessment Jamal Gasmi, MD, PhD l Vice President & Global Leader Oncology & Hematology Drug Development, ICON Clinical Research James Conklin, MD, MS l Senior Vice Pre Add to Reading List Source URL: www.aptivsolutions.com Language: English - Date: 2013-08-16 10:39:06 RTT Brain tumor Medical terminology Medical physics Cancer research Response Evaluation Criteria in Solid Tumors Imaging biomarker Glioblastoma multiforme Radiation therapy Biomarker Medical imaging Progression-free survival
4	Updated Results of Phase 1b of Tarextumab (TRXT, OMP-59R5, anti-Notch 2/3) in Combination with Etoposide and Platinum Therapy (EP) in Patients (pts) with Untreated Extensive-Stage Small Cell Lung Cancer (ED-SCLC) Copies Add to Reading List Source URL: s3.amazonaws.com Language: English - Date: 2016-06-04 05:53:42 CHOP Progression-free survival
5	Encouraging progression free survival results in subjects with newly diagnosed advanced stage renal cell carcinoma (RCC) participating in a phase II study testing the safety and activity of a dendritic cell-based immunot Add to Reading List Source URL: www.argostherapeutics.com Language: English - Date: 2013-12-05 12:55:41
6	April 23, 2015 POMALYST® (pomalidomide) Label Update Including Progression-Free and Overall Survival Benefits Approved by U.S. FDA SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced it ha Add to Reading List Source URL: www.pomalyst.com Language: English - Date: 2015-12-12 00:14:44
7	Retraction Pfizer, Inc., has recently learned that the overall response rate and progression-free survival data published in “Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 Add to Reading List Source URL: jco.ascopubs.org Language: English - Date: 2012-10-24 19:18:58
8	November 2013 PBAC Meeting Outcomes - Deferrals Drug and Form Drug Use and Type Listing Requested by Sponsor PBAC Outcome and Comments Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 17:21:09 Crizotinib Macular edema Anaplastic lymphoma kinase Macula of retina Non-small-cell lung carcinoma Progression-free survival Central retinal vein occlusion Medicine Ranibizumab Bevacizumab
9	Microsoft PowerPoint - lokhorst Kos.ppt [Read-Only] [Compatibility Mode] Add to Reading List Source URL: myeloma.org Language: English - Date: 2012-04-18 11:55:00 Transplantation medicine Hematology Hematopoietic stem cell transplantation Lymphatic system Surgical oncology Graft-versus-host disease End point of clinical trials Progression-free survival Interferon Medicine Biology Health
10	NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug Indication REGORAFENIB Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2013-10-02 06:24:46 End point of clinical trials Quality of life Progression-free survival Medical terms Medicine Health